Immediate Impact
14 standout
Citing Papers
Interstitial Lung Disease
2024 Standout
Myasthenia gravis: the changing treatment landscape in the era of molecular therapies
2024 Standout
Works of Helena Andersson being referenced
Long-term experience with rituximab in anti-synthetase syndrome-related interstitial lung disease
2015
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Helena Andersson | 187 | 56 | 100 | 79 | 7 | 213 | |
| Robert P New | 193 | 31 | 39 | 105 | 10 | 258 | |
| Lesly‐Anne Samedy | 196 | 20 | 63 | 148 | 6 | 243 | |
| C. Diéval | 116 | 32 | 65 | 67 | 8 | 159 | |
| Paloma García de la Peña Lefebvre | 89 | 53 | 34 | 52 | 13 | 137 | |
| D. Malesci | 71 | 89 | 23 | 118 | 8 | 268 | |
| Jutta Bauhammer | 99 | 34 | 39 | 62 | 6 | 122 | |
| Tiago Nardi Amaral | 56 | 143 | 43 | 38 | 9 | 271 | |
| Esthela Loyo | 100 | 53 | 17 | 127 | 9 | 262 | |
| Helena Borrell | 26 | 58 | 63 | 48 | 5 | 224 | |
| Russell Steele | 82 | 185 | 70 | 49 | 6 | 251 |
All Works
Login with ORCID to disown or claim papers
Loading papers...